152
Views
35
CrossRef citations to date
0
Altmetric
Original Articles

Adherence to Antiretroviral Therapy: Appropriate Use of Self-Reporting in Clinical Practice

, , , , , & show all
Pages 146-159 | Published online: 29 Jan 2015

REFERENCES

  • Centers for Disease Control and Prevention. Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV infected adults and adolescents. MMWR. 1998;47(No. RR-5):1–82.
  • Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1998. Updated recommendations of the International AIDS Society-USA Panel. J Am Med Assoc. 1998;280:78–86.
  • Anderson W, Weatherburn P. Taking Heart- The Impact of Combination Therapy on the Lives of People with HIV. London: Sigma Research; 1999.
  • Birch C. Implications of poor compliance. J HIV Ther. 1998;3(3):63–66.
  • Richman DD. Drug resistance and its implications in the management of HIV infection. Antiviral Ther. 1997;2\(suppl 4):41–58.
  • Anderson W, Weatherburn P. The Impact of Combination Therapy on the Lives of People with HIV. London: Sigma Research; 1998.
  • Morris LS, Schulz RM. Patient compliance - an overview. J Clin Pharm Ther. 1992;17:283–295.
  • Raynor DK. Patient compliance: The pharmacists role. Int J Pharm Pract. 1992;1: 126–135.
  • McGavrock H, Britten N, Weinman J. A Review of the Literature on Drug Adherence. London: Royal Pharmaceu-tical Society; 1996.
  • Lerner BH, Gulick RM, Neveloff Dubler N. Rethinking non-adherence: Historical perspectives on triple drug therapy for HIV disease. Ann Intern Med. 1998;129:573–578.
  • The Royal Pharmaceutical Society of Great Britain. From Compliance to Concordance: Achieving Shared Goals in Medicine Taking. London: Royal Pharmaceutical Society of Great Britain and Merck Sharpe & Dohme; 1997.
  • Myers LB, Midence K. Concepts and issues in adherence In: Myers LB, Midence K, eds. Adherence to Treatment in Medical Conditions. Amsterdam: Harwood Academic Pub-lishers; 1998:1–17.
  • Besch CL. Compliance in clinical trials. AIDS. 1995;9:1–10.
  • Ickovics JR. Behavioural science methods and measures of adherence. In: Adherence to New Antiretroviral Thera-pies. Washington DC: National Institutes of Health Office of AIDS Research; November 1997.
  • Chesney M, Ickovics J, for the Recruitment and Retention Committee of the ACTG. Adherence to combination therapy in AIDS clinical trials. Presented at: Annual meeting of the AIDS Clinical Trials Group; July 1997; Washington DC.
  • Kaplan RM, Simon HJ. Compliance in medical care: Re-consideration of self-predictions. Ann Behav Med. 1990;12:66–71.
  • Brooks GM, Richards JM, Kohler CL, Soong SJ. Assessing adherence to asthma medication and inhaler regimens: A psychometric analysis of adult self-report scales. Med Care. 1994;32(3):298–307.
  • Dunbar-Jacob J, Burke LE, Puczynski S. Clinical assess-ment and management of adherence to medical regimens. In: Nicassio PM, Smith TW, eds. Managing Chronic Illness. Washington DC: American Psychological Association; 1995.
  • Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH. The use of nitrogen mustards in the palliative treatment of carcinoma, with particular reference to bronchogenic car-cinoma. Cancer. 1948;634–666.
  • Conrad P. The meaning of medications: Another look at adherence. Social Sci Med. 1985;20(1):29–37.
  • Donovan JL, Blake DR. Patient non-adherence: Deviance or reasoned decision-making? Social Sci Med. 1992 ;34(5):507–513.
  • Conrad P. The non-compliant patient in search of au-tonomy. Hastings Center Report. 1987;17(4):15–17.
  • Hunt LM, Jordan B, Irwin S, Browner CH. Adherence and the patients perspective: Controlling symptoms in every-day life. Cultural Med Psychiatry. 1989;13:315–334.
  • Samet JH, Libman H, Steger KA, Rajeev K. Adherence with zidovudine therapy in patients infected with human immu-nodeficiency virus, type 1: A cross sectional study in a municipal hospital clinic. Am J Med. 1992;92:495–502.
  • Muma RD, Ross MW, Parcel GS, Pollard RB. Zidovudine adherence among individuals with HIV infection. AIDS Care. 1995;7(4):439–447.
  • Singh N, Squier C, Sivek C, Wagener M. Determinants of adherence with antiretroviral therapy in patients with hu-man immunodeficiency virus: Prospective assessment with implications for enhancing adherence. AIDS Care. 1996;8(3):261–269.
  • Morisky DE, Green LW, Levine DM. Concurrent and predic-tive validity of a self-reported measure of medication ad-herence. Med Care. 1986;24(1):67–74.
  • Home R. The Nature, Determinants and Effects of Medica-tion Beliefs in Chronic Illness [dissertation]. University of London; 1997.
  • Loveday HP, Robinson N, Pratt R, Pellowe C, Franks P, Loveday C. Active coping, optimism and physician support vital to adhering to antiretroviral therapy. In: Program and abstracts of the XII Conference on AIDS; June 28-July 3, 1998; Geneva, Switzerland. Abstract 32343.
  • Robinson N, Loveday H, Pellowe C, Franks P, Loveday C, Pratt RJ. Assessing individual characteristics associated with adherence to antiretroviral therapy: A new self-report tool. In: Program and abstracts of the XIII Conference on AIDS; July 9–14, 2000; Durban, South Africa. Abstract M0P0D1131:172.
  • Bakken S, Holzemer WL, Brown M-A, et al. Relationships between perception of engagement with health care pro-vider and demographic characteristics, health status, and adherence to therapeutic regimen in persons with HIV/ AIDS. AIDS Patient Care STDS. 2000;14(4):189–197.
  • Ware JE, Sherbourne CD. The MOS 36 item short form survey (SF 36): Conceptual framework and item selection. Med Care. 1992;30:473–483.
  • Reilly CA, Holzemer WL, Henry SB, Slaughter R, Portillo C. A comparison of patient and nurse ratings of human immu-nodeficiency virus-related signs and symptoms. Nurs Res. 1997;46:318–323.
  • Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.
  • Muma RD, Ross MW, Parcel GS, Pollard RB. Zidovudine adherence among individuals with HIV infection. AIDS Care. 1995;7(4):439–447.
  • Chidwick A, Borrill J. Dealing with life threatening diagno-sis: The experience of people with human immunodefi-ciency virus. AIDS Care. 1996;8(3):271–284.
  • Stansfield S, Marmot M. Deriving a survey measure of social support: The reliability and validity of the close person's questionnaire. Social Sci Med. 1992; 325(8):1027–1035.
  • DBMS / COPY. The Tool for Software Connectivity. Version 5.0. Texas: Conceptual Software Inc; 1994.
  • SPSS Inc. SPSS Base 9.0 User Guide. Chicago: SPSS Inc; 1999.
  • Tabachnik BG, Fidell LS. Using Multivariate Statistics. 3rd ed. New York: Harper Collins; 1998.
  • Jucara Arabe NPM, Rubini ACA, Rorigues DWC, Leal EHS, Freitas FS, Sion CA. Factors which influence adherence to the use of protease inhibitors. In: Program and abstracts of the XII Conference on AIDS; June 28-July 3, 1998; Geneva, Switzerland. Abstract 32404.
  • Carrieri MP, Reynaud-Maurupt C, Pradier C, Moatti JP. Compliance to multiple combination therapy with antiprotease inhibitors among HIV-infected IDUs in France (cohort MANIF 2000). In: Program and abstracts of the XII Conference on AIDS; June 28-July 3, 1998; Geneva, Swit-zerland. Abstract 32359.
  • Noakes KM, Corless IB, Brown MA, et al. Are there gender differences in HIV adherence? In: Program and abstracts of the XII Conference on AIDS; June 28-July 3, 1998; Geneva, Switzerland. Abstract 32339.
  • Haubrich RH, Little SJ, Currier JS. The value of patient reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS. 1999;13:1099–1107.
  • Chesney MA. New antiretroviral therapies: Adherence challenges and strategies. Evolving HIV treatment: Ad-vances and the challenge of adherence. In: Program and abstracts of the 37th ICAAC Symposium; September 1997; Toronto, Canada.
  • Chesney MA, Ickovicks J, Hecht FM, Sikipia G, Rabkin J. Adherence: A necessity for successful HIV combination therapy. AIDS. 1999;13(suppl A): S271–S278.
  • Broers B, Morabia A, Hirschel B. A cohort study of drug users' compliance with zidovudine treatment. Arch Intern Med. 1994;154:1121–1127.
  • Stone VE, Adelson-Mitty J, Deufield CA, Steger KA, Stein MD, Mayer KH. Adherence to protease inhibitor (P1) therapy in clinical practice: Usefulness of demographics, attitudes and knowledge as predictors. In: Program and abstracts of the XII Conference on AIDS; June 28-July 3, 1998; Geneva, Switzerland. Abstract 32337.
  • Christensen AJSTW. Personality and patient adherence: Correlates of the five factor model in renal dialysis. J Behav Med. 1995;18(3):305–313.
  • Simpson S, Woods R, Britton P. Depression and engage-ment in a residential home for the elderly. Behav Res Ther. 198119: 435–438.
  • Powell-Cope GM, Brown MA, Holzemer WL. Perceived health care providers support and HIV adherence. In: Pro-gram and abstracts of the XII Conference on AIDS; June 28-July 3, 1998; Geneva, Switzerland. Abstract 32354.
  • De Matteo MR, Sherbourne CD, Hays RD, et al. Physicians characteristics influence patients adherence to medical treatment: Results from the Medical Outcomes Study. Health PsychoL 1993;12:93–102.
  • Hecht FM, Colfax G, Swanson M, Chesney MA. Adherence and effectiveness of protease inhibitors in clinical practice. In: Program and Abstracts of the Fifth Conference on Retroviruses and Opportunistic Infections; February 1998; Chicago. Abstract 151.
  • Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Oulette VL. How often is medication taken as prescribed? A novel assessment technique. J Am Med Assoc. 1989;251:3273–3277.
  • Gelatko SM, Segarra M, Ravin DS, Babich MP. Zidovudine adherence as measured by different methods in an HIV ambulatory clinic. J Pharmacol Technol. 1996;12:105–108.
  • Waterhouse DM, Calzone KA, Mele C, Brenner DE. Adher-ence to oral tamoxifen: A comparison of patient self-report, pill counts, and microelectronic monitoring. J Clin OncoL 1993;11(6):1189–1197.
  • Ickovics JR, Meisler AW. Adherence in AIDS clinical trials: A framework for clinical research and clinical care. J Clin EpidemioL 1997;50(4):385–391.
  • Cooper JK, Love DW, Raffoul PR. Intentional prescription nonadherence (noncompliance) by the elderly. J Am Geriatr Soc. 1982;30(5):329–333.
  • Childress JK, Jhingran P, Scott Lennox J, Tolson J. Development and initial evaluation of the Patient Adherence to Medication Questionnaire (PMAQ). In: Program and ab-stracts of the Sixth European Conference on Clinical As-pects and Treatment of HIV Infection; October 11–15, 1997; Hamburg, Germany.
  • Public Health Laboratory Service. Survey of prevalent di-agnosed HIV infections. 1997. Available at: http:www.phls.co.uk/facts/hiv.htm. Accessed July 21, 1999.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.